| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.04 |